Frederick Squires · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 31 Oct 2016•Milton Keynes

Published report and response evidence

This report’s concerns and statements found in recipients’ published responses. Statements are included even where no link to an individual concern is recorded. A link shows an evidence connection; it does not assign responsibility.

View original report
Concerns
1

Raised in this report

Recipients
1

Named on the report

Responses found
1

Of 1 recipient

Stated actions
1

Described in responses

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Report evidence summary

Concerns raised1

  1. Lack of guidance on when to recommence Warfarin after head injury
    Part of recurring concern: Failure of head injury assessment and treatment pathways to reliably recognise and manage head injuriesPart of recurring concern: Unreliable guidance for medication continuation and discontinuation decisions

Stated actions An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.1

  1. National Institute for Health and Care Excellence

    Consider extending the head-injury guideline’s scope to examine evidence and develop recommendations on restarting warfarin during the 2017 update.

Respondent positions A position is what a recipient says about a concern when it does not describe a specific action.1

  1. National Institute for Health and Care Excellence

    Specific recommendations on restarting Warfarin after head injury cannot be made without extending the guideline’s scope.

    Unable to actThe respondent said that a constraint prevented them from taking the relevant action.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Lack of guidance on when to recommence Warfarin after head injury

Wider context from the report

“(1) That there is no guidance available to clinicians as to when Warfarin should be recommenced for a patient who has suffered a head injury. If clear guidance is not available it will lead to confusion amongst clinicians and the patient with the result that it is commenced too soon and the patient develops a bleed or too late and the patient suffers a stroke. ”

Is this part of a recurring concern?

Yes — Failure of head injury assessment and treatment pathways to reliably recognise and manage head injuries; Unreliable guidance for medication continuation and discontinuation decisions.

Open source report

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Consider extending the head-injury guideline’s scope to examine evidence and develop recommendations on restarting warfarin during the 2017 update.

Verbatim wording from the response

“We have a guideline on the assessment and early management of head injury (accessible from our website: www.nice.org.uk/cg176), which includes recommendations regarding discharging patients. However, we believe that to examine the available evidence and make specific recommendations on when to restart Warfarin would require the guideline’s scope to be extended. We will consider the case for doing so, when we consider the guideline for updating in 2017.”

Source location

Response from National Institute for Health and Care Excellence
Page 1 · response
Published 31 October 2016

Open published response

Source evidence

How this respondent position was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Specific recommendations on restarting Warfarin after head injury cannot be made without extending the guideline’s scope.

Verbatim wording from the response

“We have a guideline on the assessment and early management of head injury (accessible from our website: www.nice.org.uk/cg176), which includes recommendations regarding discharging patients. However, we believe that to examine the available evidence and make specific recommendations on when to restart Warfarin would require the guideline’s scope to be extended. We will consider the case for doing so, when we consider the guideline for updating in 2017.”

Source location

Response from National Institute for Health and Care Excellence
Page 1 · response
Published 31 October 2016

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Official responses located
1/1

Data last updated 7 September 2026